Structure-based design and synthesis of pyrrole derivatives as MEK inhibitors.
A novel series of pyrrole inhibitors of MEK kinase has been developed using structure-based drug design. Optimization of the series led to the identification of potent inhibitors with good pharmaceutical properties.